Home » 2013 » December (page 10)

Monthly Archives: December 2013

The new Cholesterol Guidelines 2013 pose challenges

Dear Editor, The American Heart Association (AHA) and American College of Cardiology (ACC) have released their 2013 Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

Dentist challenged Committee’s jurisdiction

Ed Madden, BL, looks at a recent UK High Court case in which a dentist challenged the jurisdiction of a General Dental Council disciplinary committee to consider fraud charges against him.

Colobreathe

Company: Forest Laboratories UK Ltd.

Zyclara

Company: Meda Health Sales.

New Indication for Eylea

Bayer Healthcare wishes to announce that Eylea (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to macular oedema secondary to Central Retinal Vein Occlusion (CRVO).

Starlix – Notice of Discontinuation

Novartis Ireland would like to advise you that Starlix, an oral antidiabetic agent used in the management of Type 2 diabetes mellitus, has been discontinued for the Irish market.